At the UF Diabetes Institute, research is one of our core missions. We know that ultimately it takes a team effort to make a difference, with families and researchers working side by side united in a common goal.
For you and your family:
Testing for autoantibodies can determine the risk of developing type 1 diabetes. UF TrialNet researchers will closely monitor people who are at moderate to high risk, and they may be eligible to participate in a prevention trial.
Currently, TrialNet has two ongoing prevention trials. Please click on the links to learn more about Anti-CD 3 (Teplizumab) and Abatacept studies for those at higher risk.
We need more participants. If you develop type 1 diabetes, UF TrialNet researchers will have the chance to diagnose you early. Researchers believe early treatment may help preserve the beta cell function longer.
For the type 1 diabetes community:
We are all in this together.
We know that family members are 15 times more likely to develop type 1 diabetes than the general population. In order to find treatments to prevent type 1 diabetes, we need family members to get involved.
For some, it is empowering to know that research participation may bring a better future for the type 1 diabetes community.
Many of the treatments we are using in prevention studies were effective in preserving the ability to make insulin in people newly diagnosed with diabetes. In order to find therapies that will prevent and someday possibly cure diabetes, we need people to take part in clinical trials